Hepatology, Medicine and Policy
2059-5166
Cơ quản chủ quản: N/A
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting
- 2018
Correction to: Hepatology, Medicine and Policy: Articles with DOIs 10.1186/s41124-016-0014-8, 10.1186/s41124-016-0013-9 and 10.1186/s41124-016-0012-x
Tập 3 Số 1 - 2018
Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces
Tập 1 - Trang 1-8 - 2016
Hepatitis C virus (HCV) imposes a considerable disease burden in China, with at
least 10 million people chronically infected. Little is known about the
financial impact of the HCV epidemic, nor about the extent to which various
forms of insurance are providing HCV patients with financial protection. A
cross-sectional multi-site study was conducted to acquire data that will aid
policy-makers and ot...
Drug consumption rooms (DCRs) as a setting to address hepatitis C – findings from an international online survey
Tập 3 Số 1 - Trang 1-11 - 2018
Prevalence of Hepatitis C Virus (HCV) among people who inject drugs (PWID) is
high. Risky injecting behaviours have been found to decrease in drug consumption
rooms (DCRs) and supervised injecting facilities (SIFs), yet HCV prevention and
treatment in these settings have not been extensively explored. To determine the
range and scope of HCV prevention and treatment options in these services, we
as...
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Tập 1 - Trang 1-3 - 2016
After introduction of new direct acting antivirals (DAAs) against hepatitis C,
the cure rate has increased substantially especially in patients with liver
cirrhosis. Decreased but remaining risk for hepatocellular carcinoma (HCC) has
been shown in patients with liver cirrhosis after cure, in previous studies with
interferon (IFN)-based treatments. This risk for HCCs is expected to become the
next ...